Related references
Note: Only part of the references are listed.Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL
Pamela M. Holland
CANCER LETTERS (2013)
Macroscopic law of conservation revealed in the population dynamics of Toll-like receptor signaling
Kumar Selvarajoo
CELL COMMUNICATION AND SIGNALING (2011)
Dynamic modeling and analysis of cancer cellular network motifs
Mathieu Cloutier et al.
INTEGRATIVE BIOLOGY (2011)
Knowledgeable individuals lead collective decisions in ants
Nathalie Stroeymeyt et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2011)
Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation
Annie Yang et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Akt-phosphorylated Mitogen-activated Kinase-activating Death Domain Protein (MADD) Inhibits TRAIL-induced Apoptosis by Blocking Fas-associated Death Domain (FADD) Association with Death Receptor 4
Peifeng Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Variability in gene expression underlies incomplete penetrance
Arjun Raj et al.
NATURE (2010)
Functional roles for noise in genetic circuits
Avigdor Eldar et al.
NATURE (2010)
Single-cell NF-κB dynamics reveal digital activation and analogue information processing
Savas Tay et al.
NATURE (2010)
Signalling ballet in space and time
Boris N. Kholodenko et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells
Jing Xu et al.
PLOS ONE (2010)
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
Constantin N. Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells
Cheng-Yun Jin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-κB inhibition
Johannes U. Ammann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells
Shannon L. Faley et al.
LAB ON A CHIP (2009)
Stochastic modelling for quantitative description of heterogeneous biological systems
Darren J. Wilkinson
NATURE REVIEWS GENETICS (2009)
Emergent Genome-Wide Control in Wildtype and Genetically Mutated Lipopolysaccarides-Stimulated Macrophages
Masa Tsuchiya et al.
PLOS ONE (2009)
Predicting Novel Features of Toll-Like Receptor 3 Signaling in Macrophages
Mohamed Helmy et al.
PLOS ONE (2009)
PPI Finder: A Mining Tool for Human Protein-Protein Interactions
Min He et al.
PLOS ONE (2009)
CAN COMPLEX CELLULAR PROCESSES BE GOVERNED BY SIMPLE LINEAR RULES?
KUMAR SELVARAJOO et al.
Journal of Bioinformatics and Computational Biology (2009)
From the determination of complex reaction mechanisms to systems biology
John Ross
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them
Andrew Thorburn et al.
DRUG RESISTANCE UPDATES (2008)
TRAU-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
Niklas Finnberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells
Hannah H. Chang et al.
NATURE (2008)
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
Jonathan C. Kagan et al.
NATURE IMMUNOLOGY (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
S. Wang
ONCOGENE (2008)
Signaling Flux Redistribution at Toll-Like Receptor Pathway Junctions
Kumar Selvarajoo et al.
PLOS ONE (2008)
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
Ailsa J. Frew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network
Sandra Morandell et al.
PROTEOMICS (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
A map of human cancer signaling
Qinghua Cui et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Survival and apoptosis: a dysregulated balance in liver cancer
Isabel Fabregat et al.
LIVER INTERNATIONAL (2007)
TRAIL signalling: Decisions between life and death
Christina Falschlehner et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Memory formation by neuronal synchronization
Nikolai Axmacher et al.
BRAIN RESEARCH REVIEWS (2006)
Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins
Nora Vazquez-Laslop et al.
JOURNAL OF BACTERIOLOGY (2006)
Discovering differential activation machinery of the Toll-like receptor 4 signaling pathways in MyD88 knockouts
K Selvarajoo
FEBS LETTERS (2006)
Noise in protein expression scales with natural protein abundance
Arren Bar-Even et al.
NATURE GENETICS (2006)
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand
E Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics
B Blagoev et al.
NATURE BIOTECHNOLOGY (2004)
TRAIL and its receptors as targets for cancer therapy
H Yagita et al.
CANCER SCIENCE (2004)
Protein kinase C zeta (PKC zeta): Activation mechanisms and cellular functions
T Hirai et al.
JOURNAL OF BIOCHEMISTRY (2003)
Stochastic gene expression in a single cell
MB Elowitz et al.
SCIENCE (2002)
Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells
A Munshi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)